4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000899243-23-003945
Chief Financial Officer sold 9,504 shares at $1.83 ($17,372)
- Chief Financial Officer acquired 265,957 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sath Chief Financial Officer | 2023-02-01 | Grant or award | +265,957 | 322,021 | D | ||
| Shukla Sath Chief Financial Officer | 2023-02-02 | Sale | −9,504 | $1.83 | $17,372 | 312,517 | D |
| Open-market sales · 9,504 sh · avg $1.83 · $17,372 | |||||||
Loading xslF345X03/doc4.xml…